Sign In
OTCMKTS:ENZN
Enzon Pharmaceuticals Stock Earnings Reports
$0.0905
-0.0095 (-9.50%)
At Close: Mar 14, 2025
Enzon Pharmaceuticals Earnings Calls
Q4 2024
| Release date | Feb 21, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0010 |
| Revenue estimate | - |
| Revenue actual | - |
Q3 2024
| Release date | Nov 05, 2024 |
| EPS estimate | - |
| EPS actual | $0.0034 |
| Revenue estimate | - |
| Revenue actual | - |
Q2 2024
| Release date | Aug 08, 2024 |
| EPS estimate | - |
| EPS actual | $0.0037 |
| Revenue estimate | - |
| Revenue actual | 26K |
Q1 2024
| Release date | May 10, 2024 |
| EPS estimate | - |
| EPS actual | $0.0043 |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Enzon Pharmaceuticals
Below you can see how ENZN performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Q1 2024
| Release date | May 10, 2024 |
| Fiscal end date | Mar 31, 2024 |
| Price on release | $0.0868 |
| EPS estimate | - |
| EPS actual | $0.0043 |
| Date | Price |
|---|---|
| May 06, 2024 | $0.0785 |
| May 07, 2024 | $0.0825 |
| May 08, 2024 | $0.0850 |
| May 09, 2024 | $0.0900 |
| May 10, 2024 | $0.0868 |
| May 13, 2024 | $0.0849 |
| May 14, 2024 | $0.0900 |
| May 15, 2024 | $0.0900 |
| May 16, 2024 | $0.0886 |
| 4 days before | 10.51% |
| 4 days after | 2.13% |
| On release day | -2.10% |
| Change in period | 12.87% |
Q2 2024
| Release date | Aug 08, 2024 |
| Fiscal end date | Jun 30, 2024 |
| Price on release | $0.140 |
| EPS estimate | - |
| EPS actual | $0.0037 |
| Date | Price |
|---|---|
| Aug 02, 2024 | $0.168 |
| Aug 05, 2024 | $0.160 |
| Aug 06, 2024 | $0.163 |
| Aug 07, 2024 | $0.170 |
| Aug 08, 2024 | $0.140 |
| Aug 09, 2024 | $0.148 |
| Aug 12, 2024 | $0.159 |
| Aug 13, 2024 | $0.148 |
| Aug 14, 2024 | $0.150 |
| 4 days before | -16.41% |
| 4 days after | 7.07% |
| On release day | 5.76% |
| Change in period | -10.50% |
Q3 2024
| Release date | Nov 05, 2024 |
| Fiscal end date | Sep 30, 2024 |
| Price on release | $0.0898 |
| EPS estimate | - |
| EPS actual | $0.0034 |
| Date | Price |
|---|---|
| Oct 30, 2024 | $0.0770 |
| Oct 31, 2024 | $0.0900 |
| Nov 01, 2024 | $0.0825 |
| Nov 04, 2024 | $0.0788 |
| Nov 05, 2024 | $0.0898 |
| Nov 06, 2024 | $0.0850 |
| Nov 07, 2024 | $0.0900 |
| Nov 08, 2024 | $0.0900 |
| Nov 11, 2024 | $0.0846 |
| 4 days before | 16.62% |
| 4 days after | -5.76% |
| On release day | -5.35% |
| Change in period | 9.90% |
Q4 2024
| Release date | Feb 21, 2025 |
| Fiscal end date | Dec 31, 2024 |
| Price on release | $0.100 |
| EPS estimate | - |
| EPS actual | -$0.0010 |
| Date | Price |
|---|---|
| Feb 14, 2025 | $0.130 |
| Feb 18, 2025 | $0.110 |
| Feb 19, 2025 | $0.102 |
| Feb 20, 2025 | $0.130 |
| Feb 21, 2025 | $0.100 |
| Feb 24, 2025 | $0.100 |
| Feb 25, 2025 | $0.0990 |
| Feb 26, 2025 | $0.0990 |
| Feb 27, 2025 | $0.100 |
| 4 days before | -23.08% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | -23.08% |
Enzon Pharmaceuticals Earnings History
Earnings Calendar
FAQ
When is the earnings report for ENZN?
Enzon Pharmaceuticals (ENZN) has scheduled its earnings report for May 08, 2025 after the markets close.
What is the ENZN price-to-earnings (P/E) ratio?
ENZN P/E ratio as of Mar 14, 2025 (TTM) is 8.63.
What is the ENZN EPS forecast?
The forecasted EPS (Earnings Per Share) for Enzon Pharmaceuticals (ENZN) for the first fiscal quarter 2025 is $.
What are Enzon Pharmaceuticals's retained earnings?
On its balance sheet, Enzon Pharmaceuticals reported retained earnings of $0 for the latest quarter ending Dec 31, 2024.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
